Heparin Inhibits Ligand Binding to the Leukocyte Integrin Mac-1 (CD11b/CD18)

Abstract

We describe a pharmacologically relevant property of heparin that may contribute to its benefits in clinical use. The binding of heparin to Mac-1 and the resulting inhibition in binding of Mac-1 ligands may directly modulate coagulation, inflammation, and cell proliferation.